TY - JOUR AU - Tomoto, Kyoichi AU - Fujimoto, Ayataka AU - Inenaga, Chikanori AU - Okanishi, Tohru AU - Imai, Shin AU - Ogai, Masaaki AU - Fukunaga, Akiko AU - Nakamura, Hidenori AU - Sato, Keishiro AU - Obana, Akira AU - Masui, Takayuki AU - Arai, Yoshifumi AU - Enoki, Hideo PY - 2021 DA - 2021/03/31 TI - Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility JO - BMC Neurology SP - 139 VL - 21 IS - 1 AB - Subependymal giant cell astrocytoma (SEGA) is occasionally seen in tuberous sclerosis complex (TSC). Two main options are currently available for treating SEGA: surgical resection or pharmacotherapy using mammalian target of rapamycin inhibitors (mTORi). We hypothesized that opportunities for surgical resection of SEGA would have reduced with the advent of mTORi. SN - 1471-2377 UR - https://doi.org/10.1186/s12883-021-02160-5 DO - 10.1186/s12883-021-02160-5 ID - Tomoto2021 ER -